Titilope Ishola

632 citations
12 papers · 516 indexed · h-index 8
Topics
Neuroblastoma Research and Treatments (7 papers)Cancer therapeutics and mechanisms (3 papers)Cell death mechanisms and regulation (2 papers)
Partner nations
United States

In The Last Decade

Titilope Ishola

12 papers receiving 514 citations

Peers

Titilope Ishola
Comparison fields: 5 of 67
  • Neurology 275
  • Molecular Biology 259
  • Cancer Research 122
  • Oncology 107
  • Cellular and Molecular Neuroscience 98
Replace Marcos Barbosa with:
Marcos Barbosa Portugal
Rick van Minkelen Netherlands
Haiyu Luo China
Sharon Liu United States
Brooke Benner United States
Vera Hummel Germany
Bing-Qiao Zhao Japan
Hans‐Peter Jüsten Germany
Casandra M. Cartagena United States
Christina von Gertten Sweden
Titilope Ishola relative to Marcos Barbosa Portugal Marcos Barbosa's profile →
Citations per field
00.5×2.6×
Marcos Barbosa · 1×
Citations per year

Countries citing papers authored by Titilope Ishola

Since Specialization
Citations

This map shows the geographic impact of Titilope Ishola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Titilope Ishola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Titilope Ishola more than expected).

Fields of papers citing papers by Titilope Ishola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Titilope Ishola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Titilope Ishola. The network helps show where Titilope Ishola may publish in the future.

Co-authorship network of co-authors of Titilope Ishola

This figure shows the co-authorship network connecting the top 25 collaborators of Titilope Ishola. A scholar is included among the top collaborators of Titilope Ishola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Titilope Ishola. Titilope Ishola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 1
2 25
3 2
4 1
5 3
6 75
7 101
8 61
9 53
10 50
11 31
12 113

About Titilope Ishola

Titilope Ishola is a scholar working on Neurology, Internal Medicine and Genetics, having authored 12 papers that have together received 516 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (7 papers), Cancer therapeutics and mechanisms (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Neurology (275 citations), Cancer Research (122 citations) and Cellular and Molecular Neuroscience (98 citations). Titilope Ishola has collaborated with scholars based in United States. Frequent co-authors include Dai H. Chung, JungHee Kang, Piotr Rychahou, B. Mark Evers, Jingbo Qiao, Michelle H. Scerbo, Volker Neugebauer, Yu Fu, Hita Adwanikar and Jeong Seok Han. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026